A Rollover Protocol of Dacomitinib For Patients In Japan

NCT02382796 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
7
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer